… record-high medical cannabis revenue, adjusted EBITDA and … to international cannabis than Q4," Martin explained. … Q4 revenue and nearly 90% of its gross profit. "All of the profitability … quot;Because these are pharmaceutical products, we believe that …

Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and introducing revenue guidance of $12-$16 million for the …

… cancer breakthroughs, multinational pharma companies to revolutionize drug … Research segment. Fourth quarter and full year revenue increased 3% … our learning segment. Q4 revenue declined 5% due to … simple. First, deliver profitable revenue growth in an uncertain …

… and year-on-year revenue and profit growth. EBIT refers to … . This expansion has supported revenue diversification, as seen in … 000 registered products and 650+ pharma formulations. Its product mix … expected to be completed by Q4 FY26, with another plant …

… East region. SUN PHARMA Sun Pharmaceutical confirmed that the US … inspections are important for pharmaceutical companies as they decide … ’s announcements during its fourth-quarter earnings report. NTPC NTPC … company can now earn revenue from power generated by …

… large order books translating into revenues and earnings." ICRA … entities) in Q4 FY2025 revealed 7.6% YoY revenue growth, supported … levels (IT, FMCG and pharmaceuticals), improved on a YoY … debt levels coupled with better profitability of India Inc. in …

… the quarter ended March 2025. “Revenue growth was largely supported by … India Inc’s operating profit margin in Q4 FY2025 improved by 63 … benefits. Overall, the operating profit margin of India Inc hit … & steel, oil and gas, pharma and sugar saw a rise …

… large order books translating into revenues and earnings,” he added. … year expansion in operating profit margins in Q4 FY2025 to 18. … levels (IT, FMCG and pharmaceuticals), improved on a YoY basis … debt levels coupled with better profitability of India Inc. in …

… the pharma company had released its fiscal fourth quarter results with … a 19 per cent YoY growth in consolidated profit … year. It posted revenue from operations at Rs … crore reported during the fourth quarter of FY24. EBITDA …

… saleable area, with an estimated revenue potential of Rs 1,500 … highest-ever quarterly profit of Rs 319 crore for Q4 FY25, a … crore, marking its first annual profit since FY18. South Indian … effective July 11. Natco Pharma: The USFDA concluded its inspection …